BLACE |
A4D250
|
B cell acute lymphoblastic leukemia expressed
|
|
|
0.931 |
0.115 |
SSBP2 |
P81877
|
single stranded DNA binding protein 2
|
|
1.00 |
0.659 |
0.269 |
HOXB4 |
P17483
|
homeobox B4
|
|
6.0E-02 |
0.647 |
0.423 |
PIP4K2A |
P48426
|
phosphatidylinositol-5-phosphate 4-kinase type 2 alpha
|
Kinase
|
0.14 |
0.647 |
0.423 |
CD52 |
P31358
|
CD52 molecule
|
|
0.40 |
0.615 |
0.500 |
MEF2D |
Q14814
|
myocyte enhancer factor 2D
|
Transcription factor
|
1.00 |
0.608 |
0.500 |
TRB |
P0DSE2
|
T cell receptor beta locus
|
|
|
0.636 |
0.538 |
PIM2 |
Q9P1W9
|
Pim-2 proto-oncogene, serine/threonine kinase
|
Kinase
|
0.95 |
0.606 |
0.538 |
FLT3LG |
P49771
|
fms related receptor tyrosine kinase 3 ligand
|
|
0.94 |
0.564 |
0.577 |
CNTNAP1 |
P78357
|
contactin associated protein 1
|
|
3.4E-05 |
0.554 |
0.577 |
PRAME |
P78395
|
preferentially expressed antigen in melanoma
|
|
2.4E-07 |
0.531 |
0.577 |
AXL |
P30530
|
AXL receptor tyrosine kinase
|
Kinase
|
1.3E-02 |
0.489 |
0.615 |
CD22 |
P20273
|
CD22 molecule
|
|
0.80 |
0.556 |
0.615 |
PCM1 |
Q15154
|
pericentriolar material 1
|
|
3.7E-16 |
0.644 |
0.615 |
FLT3 |
P36888
|
fms related receptor tyrosine kinase 3
|
Kinase
|
0.61 |
0.462 |
0.654 |
IGH |
|
immunoglobulin heavy locus
|
|
|
0.473 |
0.654 |
PAX5 |
Q02548
|
paired box 5
|
|
1.00 |
0.487 |
0.654 |
FBLIM1 |
Q8WUP2
|
filamin binding LIM protein 1
|
Enzyme modulator
|
5.4E-05 |
0.572 |
0.654 |
GOPC |
Q9HD26
|
golgi associated PDZ and coiled-coil motif containing
|
|
8.4E-04 |
0.561 |
0.654 |
ASPG |
Q86U10
|
asparaginase
|
|
6.2E-13 |
0.559 |
0.654 |
CDK2 |
P24941
|
cyclin dependent kinase 2
|
Kinase
|
0.61 |
0.456 |
0.692 |
CEBPA |
P49715
|
CCAAT enhancer binding protein alpha
|
Transcription factor
|
0.55 |
0.496 |
0.692 |
LAG3 |
P18627
|
lymphocyte activating 3
|
Receptor
|
0.28 |
0.517 |
0.692 |
MPL |
P40238
|
MPL proto-oncogene, thrombopoietin receptor
|
Receptor
|
4.1E-09 |
0.510 |
0.692 |
SPN |
P16150
|
sialophorin
|
|
1.4E-02 |
0.563 |
0.692 |